本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

16.79
+0.23001.39%
成交量:63.28万
成交额:1,052.45万
市值:22.51亿
市盈率:-9.39
高:16.88
开:16.60
低:16.36
收:16.56
52周最高:19.09
52周最低:9.60
股本:1.34亿
流通股本:8,495.06万
量比:0.76
换手率:0.74%
股息:- -
股息率:- -
每股收益(TTM):-1.7885
每股收益(LYR):-2.0595
净资产收益率:-72.92%
总资产收益率:-28.96%
市净率:6.53
市盈率(LYR):-8.15

数据加载中...

2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

重要事件披露

Form 8-K - Current report
2025/07/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

重要事件披露

Form 8-K - Current report
2025/06/17

重要事件披露

Form 8-K - Current report
2025/05/29

重要事件披露

Form 8-K - Current report
2025/05/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]